Related Experiment Video
Updated: Apr 20, 2026

In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Diadenosine tetraphosphate contributes to carbachol-induced tear secretion
Begoña Fonseca1, Alejandro Martínez-Águila, Miguel Díaz-Hernández
1Dpto de Bioquímica y Biología Molecular IV, Facultad de Óptica y Optometría, Universidad Complutense de Madrid, C/ Arcos de Jalón, 118, E-28037, Madrid, Spain.
Cholinergic stimulation of tear secretion involves purinergic mechanisms, specifically the release of adenosine tetraphosphate (Ap4A). This study reveals Ap4A
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Cholinergic agonists stimulate tear secretion.
- The precise mechanisms, particularly the involvement of purinergic pathways, remain incompletely understood.
Purpose of the Study:
- To investigate whether cholinergic stimulation of tear secretion is a direct process or mediated by purinergic mechanisms.
- To elucidate the role of specific purinergic receptors and nucleotides in carbachol-induced lacrimation.
Main Methods:
- Experiments conducted on New Zealand male rabbits.
- Tear secretion measured using Schirmer's test.
- Nucleotide levels analyzed via High-Performance Liquid Chromatography (HPLC).
- Pharmacological agents including cholinergic and purinergic antagonists, and P2Y2 receptor siRNA were utilized.
Main Results:
- Carbachol significantly increased tear secretion (84%) and Ap4A/ATP release.
- Muscarinic antagonists markedly reduced carbachol-induced tear secretion.
- Purinergic antagonists and P2Y2 receptor siRNA partially inhibited carbachol-stimulated tear secretion, with no change in Ap4A levels.
- Adenosine tetraphosphate (Ap4A) was demonstrated to participate in the lacrimal secretion process.
Conclusions:
- Cholinergic stimulation of tear secretion is partly mediated by purinergic mechanisms.
- Adenosine tetraphosphate (Ap4A) plays a significant role in regulating lacrimal gland function.
- These findings highlight the interplay between cholinergic and purinergic signaling in controlling tear production.
More Related Videos
09:04Author Spotlight: Isolating Biomolecules from Mouse Tears — A Methodology for Molecular Analysis and Biomarker Research
Published on: July 19, 2024
06:29Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
Published on: May 2, 2020
Related Concept Videos
Direct-Acting Cholinergic Agonists: Pharmacokinetics
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
GPCRs Regulate Adenylyl Cylase Activity
Direct-Acting Cholinergic Agonists: Pharmacological Actions
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...